New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Fractyl Health, Inc. (GUTS) vs Quantum Biopharma Ltd. (QNTM)

Fractyl Health, Inc. and Quantum Biopharma Ltd. are both Biotechnology companies. Fractyl Health, Inc. and Quantum Biopharma Ltd. are of similar size ($12.7M and $12.6M). Quantum Biopharma Ltd. has the higher net margin (−16,880.7% vs −75,732.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Quantum Biopharma Ltd. leads on 9 and Fractyl Health, Inc. on 5.

Valuation

Metric GUTS QNTM Biotechnology median
P/E n/m n/m 8.49
P/S 118.25 44.07 8.56
P/B n/m 1.05 2.04
Price to free cash flow n/m n/m 23.84
EV/EBITDA n/m 0.21 0.69
EV/Sales 93.73 (9.50) 8.00
Earnings yield (374.54%) (335.89%) (35.81%)
Free cash flow yield (685.81%) (104.08%) (25.41%)

Profitability

Metric GUTS QNTM Biotechnology median
Gross margin 46.24% (1,068.29%) 70.18%
Operating margin (100,570.97%) (9,699.83%) 0.00%
Net margin (75,732.26%) (16,880.72%) 0.00%
Free cash flow margin (72,350.54%) (6,089.39%) 0.00%
Return on equity 905.17% (233.09%) (51.58%)
Return on assets (82.35%) (127.92%) (45.91%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS QNTM Biotechnology median
Revenue growth (TTM) (22.50%) — 7.20%
EPS growth (last fiscal year) (14.81%) 37.50% 29.04%
Revenue growth, 5-year CAGR — — 9.54%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric GUTS QNTM Biotechnology median
Debt to equity (2.21) 0.00 0.00
Current ratio 1.98 1.72 4.79
Net debt to EBITDA 0.53 0.31 1.01

Dividend

Metric GUTS QNTM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GUTS QNTM Biotechnology median
Market cap 12.67m 12.62m 150.57m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack